XOMA Corp
NASDAQ:XOMA
XOMA Corp
NASDAQ:XOMA
Price:
25.44 USD
-1.47%
Market Closed
Updated:
May 3, 2024
XOMA Corp
Cash from Financing Activities
|
XOMA Corp
Cash from Financing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
XOMA Corp
NASDAQ:XOMA
|
Cash from Financing Activities
$120.6m
|
CAGR 3-Years
83%
|
CAGR 5-Years
32%
|
CAGR 10-Years
4%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$17.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
$21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$562.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
See Also
What is XOMA Corp's Cash from Financing Activities?
Cash from Financing Activities
120.6m
USD
120.6m
USD
Based on the financial report for Dec 31, 2023, XOMA Corp's Cash from Financing Activities amounts to 120.6m USD.
What is XOMA Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
4%
4%
The average annual Cash from Financing Activities growth rates for XOMA Corp have been 83% over the past three years , 32% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
